BRIEF INTRODUCTION ON


CLINIC RESEARCH OF
RETINITIS PIGMENTOSA WITH TREATMENT METHOD COMBINED BY TRADTIONAL CHINESE
MEDICAL SCIENCE AND
WESTERN MEDICAL SCIENCE


Retinitis pigmentosa (RP) is one of the main eye diseases inducing blindness in the world. It is a serious descendable chronic progressive vision function ebbing eye disease. The main self feeling symptoms are: night blindness, achromatopsia, eyesight ebbing continuously, field of vision gradually reducing, and finally conduce blindness.
In recent years, ophthalmic doctors are stressing on research on various aspects concerning immunogenetics, organic pathology, etc., and have obtained certain progress on aspects of opening out the essence of this disease and probing its principium of engendering. But for some questions on particular features of this disease such as: why the optic nerves become atrophy? Why the retina veins turn thinner? Where comes the pigment on the eyeground? There has been no satisfying explanation. As far as the issue of treatment, there has been no accredited report of effective treatment method. It is a acknowledged knotted disease in international ophthalmic academia.
In our hospital, the task group on “retinitis pigmentosa denaturalization treatment with method combined by traditional Chinese medical science and western medical science” have adopted treatment method of surgery combined with orally taken of Chinese traditional medicine, treated above 900 sufferers of this disease, the effectiveness rate reaches 96%. The eyesight of all treated sufferers has improved on different levels. Most of sufferers with eyesight below 0.1 have improved by several times of previous eyesight, and minority of them improve by tens of times; majority of patients with eyesight above 0.1 improves by 1 time of previous and minority by 2 up to 3 times; majority with eyesight above 0.5 can improve to above 1.0, some can even reach 1.5. The field of vision of most the treated patients have been enlarged and the pathological changes on eyeground have been meliorated, and no syndrome or sequela have occurred. During our following up period (longest for 4 years), no treated patient have been found repeating.
This treatment method has advantages such as small surgery scathe area, none impaction on inhered eyesight and field of vision, reliable curative effect, short period of treatment (normally 10 days and low charge. Hence this method is being deeply welcomed by sufferers of the disease.
This project was recommended attending “the Exhibition of Chinese Medical and Sanitary Science and Technology Achievement during the Twenty-Years’ Reforming and Opening to the World”. And it attracted attention of leaders and experts from the Sanitary Ministry and National Chinese Traditional Medical Science and Medicine Administration Authority and highly praised by them.

版权所有 © 北京明博鸿医院管理有限公司 2003--2009 视网膜色素变性研究网
电话:010-51169067 Email:mingbohong@163.com